fiercehealthcare - The Trump administration unveiled a new program to speed up Medicare coverage for breakthrough devices, touting that the new pathway cuts red tape for medical device companies to gain reimbursement. CMS said it will pause the existing TCET pathway.
AI Summary: CMS and the Food and Drug Administration launched a coordinated program to accelerate Medicare coverage for breakthrough medical devices, aiming to shorten the gap between regulatory approval and patient access. The initiative aligns agency review processes, defines eligibility, and seeks faster coverage decisions while maintaining safety and evidentiary standards.
CMS proposes mandatory bundled model for joint replacements nationwide / 7 wks
Independent study flags safety issues in ChatGPT Health triage / 3 months
Large study finds medical AI can repeat and amplify health misinformation / 3 months
Researchers report extracorporeal cross‑circulation using genetically modified pig livers / 3 months
FTC sues to stop telemarketing scheme selling fake PPO insurance / 5 wks
OpenAI debuts ChatGPT Health for integrated wellness data / 4 months
RFK Jr. launches health podcast to expose 'hypocrisy' and corruption / 7 wks
StackHealth RSS

StackHealth Time Machine
NorthFeed Inc. Terms and Conditions / Privacy Policy
Disclaimer: The information provided on this website is intended for general informational purposes only. While we strive for accuracy, we do not guarantee the completeness or reliability of the content. Users are encouraged to verify all details independently. We accept no liability for errors, omissions, or any decisions made based on this information.